Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice

Veterinary and Comparative Oncology

Volumn 10, Issue 4, 2012, Pages 274-282

  Jaroensong, T ^a   Endo, Y ^b   Lee, S J ^a   Kamida, A ^a   Mochizuki, M ^a   Nishimura, R ^a   Sasaki, N ^a   Nakagawa, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

Dogs; Ectopic; Ezrin; Metastasis; Orthotopic; Osteosarcoma

Indexed keywords

CYTOSKELETON PROTEIN; EZRIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; BONE TUMOR; CANCER TRANSPLANTATION; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OSTEOSARCOMA;

CANIS FAMILIARIS; MUS; MUS MUSCULUS;

EID: 84868596424     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2011.00294.x     Document Type: Article

References (42)

1. Dernell WS, Straw RC and Withrow SJ. Tumors of the skeletal system. In: Small Animal Clinical Oncology, 3rd edn., SJ Withrow and EG MacEwen, eds., Philadelphia, WB Saunders, 2001:378-417.
2. Dernell WS, Ehrhart NP, Straw RC and Vail DM. Tumors of the skeletal system. In: Withrow and MacEwen's Small Animal Clinical Oncology, 4th edn., SJ Withrow and DM Vail, eds., St. Louis, WB Saunders, 2007:540-582.
3. Chun R and de Lorimier LP. Update on the biology and management of canine osteosarcoma. The Veterinary Clinics of North America: Small Animal Practice 2003; 33: 491-516.
4. Mueller F, Fuchs B and Kaser-Hotz B. Comparative biology of human and canine osteosarcoma. Anticancer Research 2007; 27: 155-164.
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ. Cancer statistics, 2008. CA: A Cancer Journal for Clinicians 2008; 58: 71-96.
6. MacEwen EG. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Reviews 1990; 9: 125-136.
7. Khanna C and Hunter K. Modeling metastasis in vivo. Carcinogenesis 2005; 26: 513-523.
8. Killion JJ, Radinsky R and Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Reviews 1998; 17: 279-284.
9. Berlin O, Samid D, Donthineni-Rao R, Akeson W, Amiel D and Woods VL, Jr. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Research 1993; 53: 4890-4895.
10. Cui ZY, Ahn JS, Lee JY, Kim WS, Lim HY, Jeon HJ, Suh SW, Kim JH, Kong WH, Kang JM, Nam DH and Park K. Mouse orthotopic lung cancer model induced by PC14PE6. Cancer Research and Treatment 2006; 38: 234-239.
11. Kubota T. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. Journal of Cellular Biochemistry 1994; 56: 4-8.
12. Nakamura T, Fidler IJ and Coombes KR. Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment. Cancer Research 2007; 67: 139-148.
13. Togo S, Shimada H, Kubota T, Moossa AR and Hoffman RM. Host organ specifically determines cancer progression. Cancer Research 1995; 55: 681-684.
14. Kuo TH, Kubota T, Watanabe M, Furukawa T, Kase S, Tanino H, Saikawa Y, Ishibiki K, Kitajima M and Hoffman RM. Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Research 1993; 13: 627-630.
15. Nakajima M, Morikawa K, Fabra A, Bucana CD and Fidler IJ. Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. Journal of the National Cancer Institute Monographs 1990; 82: 1890-1898.
16. Hunter KW. Ezrin, a key component in tumor metastasis. Trends in Molecular Medicine 2004; 10: 201-204.
17. Bretscher A, Edwards K and Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nature Reviews Molecular Cell Biology 2002; 3: 586-599.
18. Böhling T, Turunen O, Jääskeläinen J, Carpen O, Sainio M, Wahlström T, Vaheri A and Haltia M. Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors. American Journal of Pathology 1996; 148: 367-373.
19. Ilmonen S, Vaheri A, Asko-Seljavaara S and Carpen O. Ezrin in primary cutaneous melanoma. Modern Pathology 2005; 18: 503-510.
20. Meng Y, Lu Z, Yu S, Zhang Q, Ma Y and Chen J. Ezrin promotes invasion and metastasis of pancreatic cancer cells. Journal of Translational Medicine 2010; 8: 61.
21. Elliott BE, Meens JA, SenGupta SK, Louvard D and Arpin M. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Research 2005; 7: R365-R373.
22. Weng WH, Ahlen J, Astrom K, Lui WO and Larsson C. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clinical Cancer Research 2005; 11: 6198-6204.
23. Elzagheid A, Korkeila E, Bendardaf R, Buhmeida A, Heikkila S, Vaheri A, Syrjänen K, Pyrhönen S and Carpén O. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Human Pathology 2008; 39: 1737-1743.
24. Moilanen J, Lassus H, Leminen A, Vaheri A, Butzow R and Carpen O. Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecologic Oncology 2003; 90: 273-281.
25. Krishnan K, Bruce B, Hewitt S, Thomas D, Khanna C and Helman LJ. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway. Clinical and Experimental Metastasis 2006; 23: 227-236.
26. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS and Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nature Medicine 2004; 10: 175-181.
27. Kim C, Shin E, Hong S, Chon HJ, Kim HR, Ahn JR, Hong MH, Yang WI, Roh JK and Rha SY. Clinical value of ezrin expression in primary osteosarcoma. Cancer Research and Treatment 2009; 41: 138-144.
28. Kim MS, Song WS, Cho WH, Lee SY and Jeon DG. Ezrin expression predicts survival in stage IIB osteosarcomas. Clinical Orthopaedics and Related Research 2007; 459: 229-236.
29. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorick R, Hewitt SM and Heiman LJ. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nature Medicine 2004; 10: 182-186.
30. Salas S, de Pinieux G, Gomez-Brouchet A, Larrousserie F, Leroy X, Aubert S, Decouvelaere AV, Giorgi R, Fernandez C and Bouvier C. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma. Virchows Archive 2009; 454: 81-87.
31. Ren L, Hong SH, Cassavaugh J, Osborne T, Chou AJ, Kim SY, Gorlick R, Hewitt SM and Khanna C. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene 2009; 28: 792-802.
32. Hong SH, Kadosawa T, Mochizuki M, Matsunaga S, Nishimura R and Sasaki N. Establishment and characterization of two cell lines derived from canine spontaneous osteosarcoma. Journal of Veterinary Medical Science 1998; 60: 757-60.
33. Barroga EF, Kadosawa T, Okumura M and Fujinaga T. Establishment and characterization of the growth and pulmonary metastasis of a highly lung metastasizing cell line from canine osteosarcoma in nude mice. Journal of Veterinary Medical Science 1999; 61: 361-367.
34. Dass CR, Ek ET, Contreras KG and Choong PF. A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clinical and Experimental Metastasis 2006; 23: 367-380.
35. Luu HH, Kang Q, Park JK, Si W, Luo Q, Jiang W, Yin H, Montag AG, Simon MA, Peabody TD, Haydon RC, Rinker-Schaeffer CW and He TC. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clinical and Experimental Metastasis 2005; 22: 319-329.
36. Yuan J, Ossendorf C, Szatkowski JP, Bronk JT, Maran A, Yaszemski M, Bolander ME, Sarkar G and Fuchs B. Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer Investigation 2009; 27: 435-442.
37. Khanna C, Prehn J, Yeung C, Caylor J, Tsokos M and Helman L. An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clinical and Experimental Metastasis 2000; 18: 261-271.
38. Bussard KM, Gay CV and Mastro AM. The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Reviews 2008; 27: 41-55.
39. Hirschfeld S and Helman L. Diverse roles of insulin-like growth factors in pediatric solid tumors. In Vivo 1994; 8: 81-90.
40. Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini P, Cremona O, Campanacci M and Comoglio PM. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 1995; 10: 739-749.
41. Seitz PK, Zhu BT and Cooper CW. Effect of transforming growth factor beta on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cells. Journal of Bone and Mineral Research 1992; 7: 541-546.
42. Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P and Helman L. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Research 2001; 61: 3750-3759.